Synonyms: ACT-539313 | ACT539313
Compound class:
Synthetic organic
|
|
No information available. |
Summary of Clinical Use |
Development for binge eating disorder was discontinued due to lack of efficacy in a phase 2 clinical study. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT04753164 | Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder | Phase 2 Interventional | Idorsia Pharmaceuticals Ltd. |